Search
for
Sort by
Research 121–150 of 297
- Tofacitinib for the treatment of alopecia areata in preadolescent children
- Tofacitinib therapy for children with severe alopecia areata
- Treatment options for alopecia: an update, looking to the future
- The Pathogenesis of Alopecia Areata in Rodent Models
- Alopecia Areata is Associated with Increased Expression of Heart Disease Biomarker Cardiac Troponin I
- The treatment of alopecia areata
- Alopecia Areata of the Beard: A Review of the Literature
- Efficacy and safety of superficial cryotherapy for alopecia areata: A retrospective, comprehensive review of 353 cases over 22 years
- Extensive alopecia areata: Not necessarily recalcitrant to therapy!
- Diseases on Hair Follicles Leading to Hair Loss Part I: Nonscarring Alopecias
- Utility of azathioprine, methotrexate and cyclosporine as steroid‐sparing agents in chronic alopecia areata: a retrospective study of continuation rates in 138 patients
- Experience with oral tofacitinib in two adolescents and seven adults with alopecia areata
- Multiple minute digitate hyperkeratosis
- Guidelines for the Management of Patients with Alopecia Areata in Korea: Part I Topical and Device-based Treatment
- Hair Follicle Targeting with Nanoparticles
- Techniques for the discovery and evaluation of drugs against alopecia
- Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata
- Detection of a Novel Missense Mutations in Atrichia with Papular Lesions
- Korean Consensus Criteria for the Severity Classification of Alopecia Areata
- Management of autoimmune associated alopecia areata
- The genetically programmed hair growth cycle and alopecia: what is there to know?
- A Comprehensive Review on Current and Future Trends of Nanoemulsions in Modern Cosmetics and Pharmaceuticals
- Real-World Experience of Tofacitinib and Baricitinib Use in Alopecia Areata in Greek Population: A Retrospective Analysis With Focus on Safety
- Alopecia Areata and Season of Onset: A Retrospective Study of 492 Cases
- Clinical Manifestation of Alopecia Areata After COVID-19 Infection or Vaccination
- New therapies for alopecia areata
- Treatments for alopecia areata: a network meta-analysis
- Alopecia Areata and Alopecia Areata Incognita
- Management of autoimmune associated alopecia areata
- A consensus-based treatment algorithm for alopecia areata in adolescents and adults: integrating severity, quality of life, and disease dynamics